Acumen Pharmaceuticals, Inc. (ABOS) Operating income 2020–2025
Acumen Pharmaceuticals, Inc. (ABOS) annual operating income history from SEC filings — each fiscal year as reported.
-$123.8MFY2025 · since FY2020: -$7.9M → -$123.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$123.8M | -8.6% |
| FY2024 | -$114.0M | -86.5% |
| FY2023 | -$61.1M | -35.2% |
| FY2022 | -$45.2M | -131.0% |
| FY2021 | -$19.6M | -147.5% |
| FY2020 | -$7.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice